Helen Reynolds

2.6k total citations
40 papers, 661 citations indexed

About

Helen Reynolds is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Helen Reynolds has authored 40 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Helen Reynolds's work include HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (7 papers). Helen Reynolds is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (7 papers). Helen Reynolds collaborates with scholars based in United Kingdom, Uganda and South Africa. Helen Reynolds's co-authors include David Back, Fiona Mulcahy, Michael Barry, S Clarke, John Tjia, Sara E. Gibbons, Jay R. Kostman, Stacey Trooskin, Giovanni Di Perri and Patrick G. Hoggard and has published in prestigious journals such as The Plant Cell, Clinical Infectious Diseases and AIDS.

In The Last Decade

Helen Reynolds

38 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Reynolds United Kingdom 15 397 199 184 134 117 40 661
Nicole White United States 16 577 1.5× 149 0.7× 319 1.7× 299 2.2× 89 0.8× 40 885
Concepta Merry Ireland 18 780 2.0× 187 0.9× 411 2.2× 216 1.6× 126 1.1× 29 1.1k
Michael Lamson United States 12 579 1.5× 140 0.7× 398 2.2× 132 1.0× 114 1.0× 25 842
Concepta Merry Ireland 12 303 0.8× 110 0.6× 138 0.8× 72 0.5× 71 0.6× 19 515
Victoria Watson United Kingdom 16 475 1.2× 107 0.5× 398 2.2× 144 1.1× 134 1.1× 32 690
Lynn McFadyen United Kingdom 16 227 0.6× 129 0.6× 153 0.8× 104 0.8× 41 0.4× 39 634
Laurie Andrews United States 12 289 0.7× 92 0.5× 86 0.5× 99 0.7× 79 0.7× 23 419
J. Gonzalez-Lahoz Spain 8 906 2.3× 76 0.4× 469 2.5× 231 1.7× 244 2.1× 9 1.0k
Akil Jackson United Kingdom 20 686 1.7× 78 0.4× 525 2.9× 197 1.5× 228 1.9× 52 888
Sandro Mancinelli Italy 15 410 1.0× 75 0.4× 143 0.8× 198 1.5× 98 0.8× 41 579

Countries citing papers authored by Helen Reynolds

Since Specialization
Citations

This map shows the geographic impact of Helen Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Reynolds more than expected).

Fields of papers citing papers by Helen Reynolds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Reynolds. The network helps show where Helen Reynolds may publish in the future.

Co-authorship network of co-authors of Helen Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Reynolds. A scholar is included among the top collaborators of Helen Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Reynolds. Helen Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brevini, Teresa, Lisa Swift, Helen Reynolds, et al.. (2025). AAV8 gene therapy for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in a patient's liver maintained ex situ for 9 days. Clinical Medicine. 25(4). 100355–100355.
2.
Hagens, Laura A., Thokozile R. Malaba, Helen Reynolds, et al.. (2025). The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2). The Pediatric Infectious Disease Journal. 44(11). 1066–1071.
3.
Lamorde, Mohammed, Landon Myer, Catriona Waitt, et al.. (2024). Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV. AIDS. 38(7). 975–981. 3 indexed citations
4.
Hale, Colin, Richard J. Fitzgerald, Helen Reynolds, et al.. (2024). A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5’-triphosphate (T-705-RTP) in human peripheral mononuclear cells. Journal of Pharmaceutical and Biomedical Analysis. 245. 116155–116155. 1 indexed citations
5.
Twimukye, Adelline, Beate Ringwald, Thokozile R. Malaba, et al.. (2024). Support, not blame: safe partner disclosure among women diagnosed with HIV late in pregnancy in South Africa and Uganda. AIDS Research and Therapy. 21(1). 14–14. 2 indexed citations
6.
Penchala, Sujan Dilly, Colin Hale, Richard J. Fitzgerald, et al.. (2023). Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 233. 115436–115436. 10 indexed citations
7.
Fitzgerald, Richard J., Laura Dickinson, Laura Else, et al.. (2022). Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 75(1). e525–e528. 14 indexed citations
8.
Twimukye, Adelline, Thokozile R. Malaba, Landon Myer, et al.. (2022). “It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda. BMC Women s Health. 22(1). 246–246. 12 indexed citations
9.
Twimukye, Adelline, Thokozile R. Malaba, Landon Myer, et al.. (2022). ‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda. BMC Pregnancy and Childbirth. 22(1). 566–566. 23 indexed citations
10.
Reynolds, Helen, et al.. (2021). A scoping review of Clinical Studies, Hospital Group Reports and National Strategic Documents on vascular access devices in cancer patients. The Journal of Vascular Access. 24(4). 575–590. 1 indexed citations
11.
Twimukye, Adelline, Thokozile R. Malaba, Catherine Orrell, et al.. (2020). Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda. BMC Public Health. 20(1). 1883–1883. 10 indexed citations
12.
13.
Trooskin, Stacey, Helen Reynolds, & Jay R. Kostman. (2015). Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy. Clinical Infectious Diseases. 61(12). 1825–1830. 44 indexed citations
14.
Reynolds, Helen, et al.. (2008). Provider perspectives on barriers to family planning quality in Uganda: a qualitative study. Journal of Family Planning and Reproductive Health Care. 34(1). 37–41. 50 indexed citations
15.
Almond, Lisa M., Marta Boffito, Patrick G. Hoggard, et al.. (2004). The Relationship between Nevirapine Plasma Concentrations and Abnormal Liver Function Tests. AIDS Research and Human Retroviruses. 20(7). 716–722. 39 indexed citations
16.
Boffito, Marta, Antonella Rossati, Helen Reynolds, et al.. (2002). Short Communication: Undefined Duration of Opiate Withdrawal Induced by Efavirenz in Drug Users with HIV Infection and Undergoing Chronic Methadone Treatment. AIDS Research and Human Retroviruses. 18(5). 341–342. 14 indexed citations
17.
Boffito, Marta, Riccardo Raiteri, Stefano Bonora, et al.. (2002). Clinical use of lopinavir/ritonavir in a salvage therapy setting. AIDS. 16(15). 2081–2083. 56 indexed citations
18.
Back, David, Saye Khoo, Sara E. Gibbons, et al.. (2001). Therapeutic drug monitoring of anti-HIV drugs. International Congress Series. 1220. 145–160. 1 indexed citations
19.
Clarke, S, Fiona Mulcahy, John Tjia, et al.. (2001). The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz. British Journal of Clinical Pharmacology. 51(3). 213–217. 115 indexed citations
20.
Reynolds, Helen, et al.. (1994). New imperatives for internal medicine residency education.. PubMed. 96(3). I–IV. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole White Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by Michael Lamson Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by Victoria Watson Breakdown of academic impact, for papers by Lynn McFadyen Breakdown of academic impact, for papers by Laurie Andrews Breakdown of academic impact, for papers by J. Gonzalez-Lahoz Breakdown of academic impact, for papers by Akil Jackson Breakdown of academic impact, for papers by Sandro Mancinelli
Rankless by CCL
2026